Topics

Novartis licenses global rights to Pliant's PLN1474 for NASH

19:40 EDT 25 Oct 2019 | Elsevier Business Intelligence

Novartis AG licensed exclusive worldwide development and commercialization rights to Pliant Therapeutics Inc.'s preclinical P...

Original Article: Novartis licenses global rights to Pliant's PLN1474 for NASH

NEXT ARTICLE

More From BioPortfolio on "Novartis licenses global rights to Pliant's PLN1474 for NASH"

Quick Search

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...